We would like to extend a heartfelt thank you to everyone who contributed to this achievement, and to our members, collaborators, funders and supporters who have helped make this possible.

We can't wait to welcome delegates to our biggest-ever annual conference next week in Birmingham! We've got an ambitious programme of talks, workshops and more, packed with valuable insights on treatment, care and research. See you there! 👋🤩 bit.ly/4hs4bPR #CCLG2025

Why have CCLG and TYAC merged their memberships to form a new professional association? To foster greater collaboration, enhance access to resources, and build a stronger community dedicated to advancing treatment, care and support for #CYP with cancer 💛 www.cclg.org.uk/news-updates...

Oh my days....70 years in the making!

I’m pleased to be speaking at the @cancerresearchuk.org upcoming children’s & young people’s cancers webinar on exploring further discoveries from clinical research. Join me on 12 February from 3–4:30 pm (GMT): bit.ly/3BsXMF0 #ExploringCYPCancers @nucancer.bsky.social

Catch me getting mean at the Carlton Club Manchester on 4th February alongside brilliant comedy minds @martinmerry.bsky.social @erinbeeston.bsky.social @katedoingscience.bsky.social @maxmatics.bsky.social Photo credit @drstevex.bsky.social

PhD post available: Are you interested in using contemporary ‘omics approaches to uncover clinically-relevant biology in medulloblastoma, the most common malignant brain tumour in children? Join our Childhood Brain Tumour Research team @nucancer.bsky.social See www.findaphd.com/phds/project...

PhD post available: Are you interested in using contemporary ‘omics approaches to uncover clinically-relevant biology in medulloblastoma, the most common malignant brain tumour in children? Join our Childhood Brain Tumour Research team @nucancer.bsky.social See www.findaphd.com/phds/project...

In this Review, Tao et al. discuss the origins and heterogeneity of pediatric medulloblastoma, through the molecular lens of cerebellar development, for the advancement of disease modeling, treatment and outcomes. #OpenAccess Learn more here: ➡️ tinyurl.com/gd351936

ZIC1 is a context-dependent medulloblastoma driver in the rhombic lip www.nature.com/articles/s41...

Interesting paper now published in Science👇🏻 www.science.org/doi/10.1126/...

Delighted to see that Christine Harrison has been awarded an OBE in the NY Honours List. A wonderful recognition for excellent childhod leukaemia research. Congratulations! #leukaemia #newcastleuniversity #lrcg #research #cancer #leukemia @nucancer.bsky.social bloodcancer.org.uk/news/blood-c...

Happy Holidays！💐 Credit to: Dario Brunetti

🎉 We're celebrating being listed one of the world's top 60 universities for sustainability by QS. We're also joint 3rd in the world for health and wellbeing impact - recognising our mission to help people around the globe live longer and healthier lives. #WeAreNCL #QSWUR

We are one of just 7 UK cancer centres that are contributing to the CRUK Black Leaders in Cancer PhD Scholarship Programme. We have 10 exciting projects on offer to eligible candidates of Black heritage backgrounds. Read more about the scheme and what we have on offer www.ncl.ac.uk/cancer/train...

Did you know that scientists in our @cruk-si.bsky.social Drug Discovery Unit were the brains behind Rucaparib (PARP inhibitor) and Erdafitinib (FGFR inhibitor, both now clinically approved cancer medicines. Read more about our ground breaking drug discovery science here www.ncl.ac.uk/cancer/our-r...